Potential for Production of Kencur (Kaempferia galanga L.) Secondary Metabolites with Auxin and Cytokinin in vitro

In Indonesia, galangal is a common rhizome plant that is grown in yards.Galangal can be used as a spice, a base for traditional Indonesian herbal medicine, or as an ingredient in other pharmaceutical products.In reality, the production of Kencur plants should be focused on the quality of the plant's rhizomes, which will subsequently serve as raw materials for the pharmaceutical industry, rather than just quantity, as is typically the case.There are a lot of beneficial secondary metabolites in the galangal rhizome.Kencur produces several significant bioactive ingredients, including ethyl P-Methoxycinnamate (EPMC).Issues in the field revealed several barriers to galangal cultivation, such as the long harvesting season, the lengthy growing season for planting material, and low quality.In vitro cultivation is one method that can be used to create Kencur's secondary metabolites.The key to successful in vitro cultivation is the administration of growth regulators.More research is needed to determine the best growth regulator type, combination, and concentration for high-quality in vitro Kencur production.The primary objective of this review is to explore the potential for producing secondary metabolites from Kencur using in vitro techniques with the application of auxin and cytokinin.

Перевод пока недоступен